Catalent has announced the completion of a $3.2 million expansion programme at its consumer health manufacturing facilities in Strathroy, Canada and Sorocaba, Brazil
The expansion projects include new softgel encapsulation lines at each site, dedicated to Catalent’s proprietary Vegicaps plant-based capsule and CosmoPod twist-off capsule technologies.
The increased capacity will enable Catalent to support its customers in both North and Latin America to develop products for consumers seeking all-natural and plant-based vitamins, minerals and supplements, using its Vegicaps capsule; and those looking for innovative, easy-to-use, unit-dose beauty care products, through its CosmoPod technology.
“We have seen increased consumer demand for greater product choice, with sales of plant-based softgel technologies growing by more than 25% globally in recent years."
"Additionally, Brazil has grown to become the world’s fourth-largest market for beauty care products,” commented Dr Aris Gennadios, President, Softgel & Oral Technologies, Catalent.
“While we have been supplying the North and Latin American markets with plant-based softgel capsules from our manufacturing sites in Italy and Germany, this investment allows us to provide local supply solutions to markets that complement existing capabilities in Europe.”
Catalent’s 110,000 square-foot facility in Strathroy, Ontario, and its 124,600 square-foot facility in Sorocaba, Brazil, both offer a broad range of integrated formulation, manufacturing, and packaging services to provide full-service turnkey solutions for the pharmaceutical, consumer health and beauty industries.